Eli Lilly Corp. buy BMO Capital Markets
Start price
07.02.24
/
50%
€666.00
Target price
07.02.25
€802.46
Performance (%)
12.36%
Price
17:44
€745.90
Summary
This prediction is currently active. The prediction currently has a performance of 12.36%. Dividends of €2.41 are taken into consideration when calculating the performance. This prediction currently runs until 07.02.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | 5.223% | 5.223% |
iShares Core DAX® | -0.654% | 1.989% |
iShares Nasdaq 100 | 0.903% | 5.664% |
iShares Nikkei 225® | -0.740% | -1.363% |
iShares S&P 500 | -0.013% | 3.020% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $710.00 to $865.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat